NVAX
(NASDAQ)Novavax, Inc.
$10.22-- (--)
Loading... - Market loading
Novavax (NVAX) Stock Price & Financial Analysis
Novavax Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$10.05 - $10.75
52-Week High$11.97
52-Week Low$6.20
Open$10.50
Volume4.98M
Average Volume (3M)4.56M
Market Cap1.67B
Shares Outstanding163.28M
Price to Sales (P/S)2.80
Price to Book (P/B)-11.53
EV/EBITDA-50.31
Revenue (TTM)596.34M
Net Income (TTM)-87.83M
Free Cash Flow (TTM)-97.45M
EPS (TTM)$-0.52
Profit Margin-14.73%
Operating Margin-11.97%
50-Day MA$8.58
200-Day MA$8.55
52-Week Change29.37%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Day's Range$10.05 - $10.75
52-Week High$11.97
52-Week Low$6.20
Open$10.50
Volume4.98M
Average Volume (3M)4.56M
Market Cap1.67B
Shares Outstanding163.28M
Price to Sales (P/S)2.80
Price to Book (P/B)-11.53
EV/EBITDA-50.31
Revenue (TTM)596.34M
Net Income (TTM)-87.83M
Free Cash Flow (TTM)-97.45M
EPS (TTM)$-0.52
Profit Margin-14.73%
Operating Margin-11.97%
50-Day MA$8.58
200-Day MA$8.55
52-Week Change29.37%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Frequently Asked Questions About Novavax
What is the current stock price for NVAX?
As of the latest trading session, NVAX stock trades at $10.22. The 52-week range is $6.20–$11.97, with a day range of $10.04–$10.75.
What is the P/E ratio for NVAX?
The P/E ratio (Price-to-Earnings) for NVAX is shown in the Key Statistics section. This valuation metric helps compare Novavax, Inc. to industry peers.
Does NVAX pay dividends?
Novavax does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NVAX?
Based on 12 analysts, the consensus for NVAX is Buy.
What is the market cap of NVAX?
Novavax's market capitalization is $1.67B, classifying it as a small-cap company. Novavax operates in the Healthcare sector within the Biotechnology industry.